Chiara Stagnaro

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

Dinesh Khanna, Yannick Allanore, Christopher P. Denton et al. · Annals of the Rheumatic Diseases · 2020 · 107 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study

Serena Colafrancesco, Roberta Priori, Guido Valesini et al. · Frontiers in Pharmacology · 2017 · 106 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Prognostic Value of Lung Ultrasound B-Lines in Systemic Sclerosis

Luna Gargani, Cosimo Bruni, Chiara Romei et al. · CHEST Journal · 2020 · 94 citations

Medicine, Radiology, Pulmonology +10

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study

Antonio Vitale, Antonella Insalaco, Paolo Sfriso et al. · Frontiers in Pharmacology · 2016 · 88 citations · Full text

Medicine, Immunology, Pharmacotherapy +12

Remission and low disease activity in systemic lupus erythematosus: an achievable goal even with fewer steroids? Real-life data from a monocentric cohort

Chiara Tani, R Vagelli, Chiara Stagnaro et al. · Lupus Science & Medicine · 2018 · 83 citations · Full text

Life Sciences, Clinical Sciences, Immunology +15